期刊
JOURNAL OF CONTROLLED RELEASE
卷 273, 期 -, 页码 51-67出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2018.01.021
关键词
Stimuli-responsive, nanoparticles; Bone therapeutics delivery; Controlled release
资金
- European Research Council [ERC-2014-ADG-669858]
- Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/119983/2016]
The development of stimuli-responsive nanomedicines with tunable cargo release is gathering an increased applicability in bone regeneration and precision biomedicine. Yet, the formulation of nanocarriers that explore skeletal-specific stimuli remains remarkably challenging to materialize due to several endogenous and disease-specific barriers that must be considered during particle design stages. Such anatomo-physiological constrains ultimately hinder nanocarriers bioavailability in target bone tissues and impact the overall therapeutic outcome. This review aims to showcase and critically discuss the hurdles encountered upon responsive nanocarriers delivery in the context of skeletal diseases or tissue regeneration scenarios. Such focus is complemented with an in-depth and up-to-date analysis of advances in the development of stimuli-responsive, bone-focused delivery systems. In a holistic perspective, a deeper knowledge of human osteology combined with advances in materials functionalization via simple precision-chemistry is envisioned to incite the manufacture of stimuli-triggered nanomedicines with more realistic potential for clinical translation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据